Use of NSAIDs via the Rectal Route for the Prevention of Pancreatitis after ERCP in All-Risk Patients: An Updated Meta-Analysis
The aim of this study was to assess the efficacy of the rectal administration of nonsteroidal anti-inflammatory drugs (NSAIDs) in preventing post-ERCP pancreatitis (PEP). We searched database for randomized controlled trials (RCTs) comparing periprocedural rectal administration of NSAIDs with placeb...
Saved in:
Main Authors: | Lei-Min Yu, Ke-Jia Zhao, Bin Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2018/1027530 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Do NSAIDs Prevent Colorectal Cancer?
by: Nadir Arber
Published: (2000-01-01) -
Modern approaches of effective prevention of NSAIDs-gastropathy
by: A. Ye. Karateyev
Published: (2015-12-01) -
Rectal Indomethacin Is Protective against Pancreatitis after Endoscopic Retrograde Cholangiopancreatography: Systematic Review and Meta-Analysis
by: Xingkang He, et al.
Published: (2018-01-01) -
Ketamine Use for Successful Resolution of Post-ERCP Acute Pancreatitis Abdominal Pain
by: Suneel M. Agerwala, et al.
Published: (2017-01-01) -
Cardiorenal Effects of Newer NSAIDs (Celecoxib) versus Classic NSAIDs (Ibuprofen) in Patients with Arthritis
by: Ragia Hegazy, et al.
Published: (2011-01-01)